SCHEMBL7520566

SCHEMBL7520566

Cc1cccc([SiH2]CSc2cc(C(C)C)c(O)cc2C(C)C)c1C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.34
MAPT P10636 4/20 0.33
NPSR1 Q6W5P4 3/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
TRPA1 O75762 2/20 0.33
CHRM1 P11229 1/20 0.33
SLC6A2 P23975 1/20 0.33
ADRA1A P35348 1/20 0.33
HTR2B P41595 1/20 0.33
ATM Q13315 1/20 0.33
CYP1A2 P05177 4/20 0.32
CYP3A4 P08684 3/20 0.32
CYP2C19 P33261 3/20 0.32
CYP2D6 P10635 3/20 0.32
PKM P14618 2/20 0.32
CYP2C9 P11712 2/20 0.32
ALOX15 P16050 2/20 0.32
HIF1A Q16665 2/20 0.32
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27497914 0.82 THRA (0.36) LMNAMAPTNPSR1KMT2AMEN1
SCHEMBL8379346 0.79 TRPA1 (0.33) TRPA1ATM
SCHEMBL7526769 0.78 TRPA1 (0.37) MAPTNPSR1TRPA1ATMCYP1A2
SCHEMBL8441767 0.77 TRPA1 (0.43) LMNAMAPTTRPA1ATMGAA
SCHEMBL7525526 0.76 TRPV1 (0.36) LMNAMAPTNPSR1KMT2AMEN1
SCHEMBL7517853 0.73 SHBG (0.36) MAPTTRPA1ATMGAAHSD17B10
SCHEMBL7521986 0.72 HMGCR (0.33) TRPA1ATM
SCHEMBL7520622 0.71 FAAH (0.34) LMNAKMT2AMEN1SLC6A2HTR2B
SCHEMBL27535171 0.70 ESR1 (0.39) LMNAMAPTKMT2AMEN1TRPA1
SCHEMBL8390395 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0900225-B1 ALKYL-4-SILYL-PHENOLS AND ESTERS THEREOF AS ANTIATHEROSCLEROTIC AGENTS AVENTIS PHARMA INC (US) 2002-01-30 EP disclosed
US-5608095-A Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents HOECHST MARION ROUSSEL, INC. (US) 1997-03-04 US disclosed